Jefferies Financial Group’s Revolution Medicines RVMD Stock Holding History

Jefferies Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242K	Sell	2,490 -1,138,705	-100%	-$115M	﹤0.01%	1446
2025 Q4	$90.9M	Buy	1,141,195 +1,128,195	+8,678%	+$74M	0.46%	32
2025 Q3	$607K	Sell	13,000 -2,788	-18%	-$109K	﹤0.01%	1020
2025 Q2	$581K	Sell	15,788 -147,509	-90%	-$5.67M	﹤0.01%	867
2025 Q1	$5.77M	Buy	163,297 +140,572	+619%	+$5.71M	0.05%	256
2024 Q4	$994K	Buy	+22,725	New	+$1.15M	0.01%	884
2024 Q2	–	Sell	-30,422	Closed	-$981K	–	1819
2024 Q1	$981K	Sell	30,422 -42,932	-59%	-$1.27M	0.01%	834
2023 Q4	$2.1M	Buy	+73,354	New	+$1.76M	0.01%	694

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jefferies Financial Group's RVMD Position: Q1 2026 in Review

Jefferies Financial Group reduced its Revolution Medicines (RVMD) stake by 100% in Q1 2026, selling an estimated $115M and leaving 2,490 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Jefferies Financial Group first reported a position in RVMD in Q4 2023 and has held it in 8 quarters since. The position peaked at $90.9M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Jefferies Financial Group held 2,490 shares of Revolution Medicines worth $242K as of Q1 2026.
Jefferies Financial Group sold 1,138,705 Revolution Medicines shares in Q1 2026, an estimated $115M.
Revolution Medicines made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1446 holding.
Jefferies Financial Group first reported a position in Revolution Medicines in Q4 2023 and has held it in 8 quarters since.
Jefferies Financial Group's Revolution Medicines position peaked at $90.9M in Q4 2025.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.